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INTRODUCTION 
 Thyroid gland is unique among endocrine organs. It is the largest 
of all the endocrine glands. Because of its superficial location, it is the 
only gland that is amenable to direct physical evaluation, cytological 
evaluation and histopathological study. 
 The modern procedure of Fine needle aspiration cytology has 
found world wide acceptance in clinical use as a quick and reliable  
diagnostic modality. The method is applicable to lesions that are easily 
palpable. For ex. Superficial growths of the skin, subcutis, soft tissues 
and organs such as the thyroid, breast, salivary glands and lymph nodes. 
 The technique is relatively painless produces a speedy result and is 
cost effective. It is less complicated than surgical biopsy and so is very 
suitable for practice in countries with limited resources. The low risk of 
complications is an additional advantage which allows Fine needle 
aspiration cytology to be performed as an out patient procedure. 
Fine needle aspiration cytology has become an area for research 
both fundamental and clinical. One can visualize the increasing use of 
Electron microscopy and immuno cytochemistry of  Fine needle 
aspiration samples and smears. It has been established that morphometric 
technique applied to Fine needle aspiration preparations can aid not only 
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in diagnosis of malignancy but also in assessing prognosis and selection 
of appropriate therapy.  
Fine needle aspiration cytology of the thyroid gland is firmly 
established as a first line diagnostic test for the evaluation of goiter and 
the single most effective test for the preoperative diagnosis of a solitary 
thyroid nodule. 
The main indications for Fine needle aspiration  are 
1. The diagnosis of diffuse non toxic goiter. 
2. The diagnosis of the solitary or dominant thyroid nodule. 
3. Confirmation of clinically obvious thyroid malignancy 
4 To obtain material for special laboratory investigations aimed at 
defining prognostic  parameters. 
 The experience as well as the expertise of the cytopathologist is 
critical in avoiding pitfalls. Determining the adequacy of an aspirate, 
cellular atypia, application and interpretation of immunostains and 
differentiation of lymphocytic thyroiditis from lymphoma are but a few of 
these problems. 
 Hurthle cells are of uncertain significance in thyroid disease and 
this study tries to clarify the meaning and predictivity of Hurthle cells in 
Fine needle aspirartion cytology for thyroid nodular disease. 
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AIM OF THE STUDY 
 There has been renewed interest in the diagnosis and treatment of 
Hurthle cell lesions because of the increasing use of fine needle aspiration 
biopsy in the preoperative diagnosis of thyroid nodules. 
 The aim of our study are 
 1. Significance of  Hurthle cells in the thyroid cytology. 
 2. Cytologic features that would differentiate reliably between 
Hurthle cell neoplasm and non - neoplastic Hurthle cell 
lesions. 
 3. To aid in decision of therapeutic management of patients 
with Hurthle cells in cytology. 
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MATERIALS AND METHODS 
 The present study was under taken in the Department of pathology 
Madras Medical College, Tamil Nadu, India and Department of Surgical 
Endocrinology, Govt. General Hospital Chennai for a period of one year 
from Jan 2005 -Dec 2005. 
 The cytological materials were obtained in the form of smears 
which were fixed in 95% alcohol for Haematoxylin and Eosin stain and 
methanol for May Grunwald Giemsa stain. The aspiration syringes used 
were 5ml and the needle size between 22-23 gauges. 
Procedure 
 The thyroid gland is palpated carefully and the nodule(s) to be 
biopsied identified. The procedure is explained to the patient carefully. 
The patient is placed supine with the neck hyperextended to expose the 
thyroid. For support a pillow is placed under the shoulders. The patient is 
asked not to swallow, talk or move during the procedure. After the 
aspiration firm pressure is maintained on the biopsy site. The patient is 
asked to sit for a few minutes. Occasionally patients complain of 
dizziness or pain. It is best to observe the patients for a few minutes. 
 Usually 2-3 aspirates and preferably the aspirates should be 
obtained from the peripheral areas and different parts of the nodule in a 
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sequential manner to ensure representative sampling. For cystic lesions 
the fluid should be aspirated and fine needle aspiration cytology 
attempted on residual tissue16. 
Haematoxylin and Eosin Stain35 
 Fix in 95% alcohol for 20 minutes. 
 Stain in Haematoxylin for 5 minutes. Wash in water. 
 Dip in 0.5% acid alcohol for a few seconds. 
 Blueing in tap water for 20 minutes. 
 Dip in Eosin stain for 1 minute. Wash in water. 
 Dry and mount the slide. 
May Grunwald Giemsa Stain 
 May Grunwald - Giemsa both comes as a solution. Before use for. 
May Grunwald stain dilute with equal volume of buffer water (pH 6.8) 
for Giemsa Dilute one part of stain with 9 parts of buffer water. 
Fix in methanol 15 minutes. 
 Stain in May Grunwald 10 minutes 
 Stain in Giemsa 15 minutes 
 Rinse in Buffer water PH 6.8 for 5 - 7 minutes and allow it to dry. 
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Buffer Water Preparation 
 A buffer is a solution which tends to keep its original pH even on  
addition of small amounts of either acid or alcohol. 
Solution No.1 
 Sodium Hydroxide 8g 
 Distilled Water 1,000 ml 
Solution No. 2 
 Potassium dihydrogen phosphate 27.2g 
 Distilled Water 1,000 ml 
 Take 23.7 ml of solution No.1 and add it to 50ml of solution No.2 
Add 20ml of the above mixed buffer solution to 1,000 ml of distilled 
water. Check the pH. This should have a pH of 6.8. Label the bottle and 
use this for the diluting with the blood film staining. 
For tissue sections the specimens were fixed in formalin. After 
paraffin embedding 4 micron thick sections were made and stained with 
Haematoxylin and Eosin35. 
Results of  Fine needle aspiration may be grouped as diagnostic 
(satisfactory) or non diagnostic (unsatisfactory) 
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Diagnostic 
      
Benign Malignant Indeterminate 
Colloid Nodules Primary thyroid cancer  
Benign Cysts Metastatic malignancy  
Hashimoto's thyroiditis   
Granulomatous 
thyroiditis 
  
 
The indeterminate category includes smears with features 
suggestive of but not diagnostic for malignancy. Aspirates with too few 
follicular cells or only degenerative foam cells are labelled non - 
diagnostic. 
For assessing cellularity, the rule of thumb of six groups of normal 
- appearing thyroid epithelial cell should be well fixed and well stained, 
appear unremarkable and benign and should not be excessively 
degenerated. A group is defined as 15 -20 thyroid epithelial cells in a 
sheet or follicular group. For assessing the adequacy of specimens, 
degenerative foam cells are not counted because they are encountered in 
both benign and malignant (especially papillary) conditions. 
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DEVELOPMENTAL BIOLOGY AND 
ANATOMY OF THE THYROID 
Structural Embryology 
 The human thyroid anlage is first recognizable about 1 month after 
conception when the embryo is approximately 3.5 - 4 mm in length. The 
primordium begins as a thickening of epithelium in the pharyngeal floor, 
which later forms a diverticulum. With continuing development, the 
median diverticulum is displaced caudad and the primitive stalk 
connecting the primordium with the pharyngeal floor elongates 
(thyroglossal duct). During its caudal displacement the primordium 
assumes a bilobate shape coming into contact and fusing with the ventral 
aspect of the fourth pharyngeal pouch. 
 Normally the thyroglossal duct undergoes dissolution and 
fragmentation by about second month after conception, leaving at its 
point of origin a small dimple at the junction of the middle and posterior 
thirds of the tongue the foramen caecum. Cells of the lower portion of the 
duct differentiate into thyroid tissue forming the pyramidal lobe of the 
gland. Concomitantly histological alterations occur throughout the gland. 
Complex interconnecting cord like arrangements of cells interspersed 
with vascular connective tissue replace the solid epithelial mass and 
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becomes tubule like structures at about the third month of fetal life. 
Shortly thereafter follicular  arrangements devoid of colloid appear and 
eventually follicles fill with colloid33. 
Functional Ontogeny  
The ontogeny of thyroid function and its regulation in the human 
fetus are fairly well defined. Future follicular cells acquire the capacity to 
form thyroglobulin as early as the 29th day of gestation, whereas the 
capacities to concentrate iodide and synthesize T4 are delayed until about 
the eleventh week. Radio active iodine inadvertently given to the mother 
would be accumulated by the fetal thyroid soon thereafter. 
Because the capacity of the pituitary to synthesize and secrete TSH 
is not apparent until the 10th 12th weeks early growth and development 
of the thyroid do not seem to be TSH dependent. Subsequently rapid 
changes in pituitary and thyroid function takes place. Probably as a 
consequence of hypothalamic maturation and increasing secretion of 
thyrotropin releasing hormone the serum TSH concentration increases 
between 18 - 26 weeks of gestation.  
Thyroxine binding globulin is detectable in the serum by 10th 
gestational week. There is progressive increase in T4 concentration 
during second and third trimesters33.  
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Anatomy of the thyroid gland  
Following the work of bartholomaeus Eustachius of Rome in the 
1700s, the gland acquired the name " Glandulum Thyroideam' (Latin for 
shield shaped)7.  
The thyroid gland consists of two bulky lateral lobes connected by 
a relatively thin isthmus, usually located below and anterior to the larynx. 
Normal variations in the structure of the thyroid gland include the 
presence of a pyramidal lobe, a remnant of the thyroglossal duct above 
the isthmus.  
The weight of the normal adult thyroid is approximately 15 - 
25gm. The thyroid has a rich intra glandular capillary network that is 
supplied by the superior and inferior thyroidal arteries. Nerve fibres from 
the cervical sympathetic ganglia indirectly influence thyroid secretion by 
acting on the blood vessels3.  
Physiology  
Homeostasis in the hypothalamus - pituitary - thyroid axis and 
mechanism of action of Thyroid hormones.  
Secretion of thyroid hormones is controlled by trophic factors 
secreted by both the  hypothalamus and the anterior pituitary. Decreased 
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levels of T3 and T4 stimulate the release of thyrotropin releasing 
hormone from the hypothalamus and thyroid stimulating hormone from 
the pituitary causing T3 T4 levels to rise.  
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Elevated T3 and T4 levels inturn suppress the secretion of both 
thyrotropin releasing hormone (TRH) and thyroid stimulating hormone 
(TSH). This relationship is termed negative feed back loop. TSH binds to 
the TSH receptor on the thyroid follicular epithelium which causes 
activation of G proteins and cyclic AMP mediated synthesis and release 
of thyroid hormones. In the periphery T3 and T4 interact with the thyroid 
hormone receptor to form a hormone receptor complex that translocates 
to the nucleus and binds to so called thyroid response elements on target 
genes initiating transcription3.  
Light microscopic appearance   
Microscopically the thyroid is divided into lobules composed of 
about 20 - 40 follicles. It is estimated that approximately three million 
follicles are present in the thyroid of an adult man. Each lobe or lobule is 
supplied by an intra lobular artery and vein. The follicles are lined by 
epithelial cells which surround central deposits of colloid. In general the 
follicles range from uniform to variable size however the plane of section 
may give the appearance of small follicles interspersed with larger ones. 
In the interfollicularstoma and occasionally abutting between the 
epithelial cell are individual or small groups of Para follicular `C' cells40.  
Thyroid function test   
Methods for evaluating thyroid function have been divided by 
Cavalieri into  
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a) Those which measure effects of thyroid hormone such as basal 
metabolic rate. 
b) Those measuring thyroid iodine metabolism.  
c) Those which measure circulating thyroid hormones.  
d) Those which assess feed back and control mechanisms.  
Thyroid Iodine Metabolism  
Radionuclide Uptake  
Radio active iodine injected into an individual will be 
preferentially trapped by the thyroid gland. Measurement of radio activity 
over the thyroid  several time intervals allows an estimation of the ability 
of the thyroid to trap iodine, organify it and  accumulate isotope 
presumably producing T4 and T3.  
Measurement of Circulating Thyroid hormones  
Free T4 and Free T3 
Normal values include free T4 of 2.0ng/dl and Free T3 of 0.33 
ng/dl. These hormones are elevated in 95 - 100% of hyper thyroid 
patients. T4 is decreased in all hypothyroid individuals whereas T3 may 
be normal in about 30%.  
Tests of Feed back mechanisms  
Measurements of TSH by radio immuno assay has become a useful 
diagnostic tool. Normal range is approximately 0.5 - 50 mu/L. Elevated 
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levels of this hormone are often found in hypothyroid states. TSH levels 
rise early in hypothyroidism and this test in exquisitely sensitive as the 
initial indicator of hypofunction.  
The TRH stimulation test - TRH, the tripeptide hypothalamic 
hormone can be injected to test the integrity of the hypothalamic - 
pituitary axis. This test may be helpful in the distinction  of primary from 
secondary hypothyroidism. If a hypothyroid patient with a non - elevated 
TSH level shows a brisk risk in TSH after TRH administration, the 
pituitary is intact, on the other hand if TSH response is blunted the results 
suggests an intrinsic pituitary abnormality as the cause of 
hypothyroidism40.  
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11Algorithm for the evaluation  of the thyroid nodule 
FINE NEEDLE ASPIRATION 
 
        
Benign 
(Hashimoto's 
colloid nodule 
follicular lesion) 
Inadequate Indeterminate Malignant, 
Suspicious 
        
Follow Repeat FNA 
(Ultrasound 
guided) 
I123 Scan  Cold 
       or Warm 
 
 
Surgery 
     Hot  
Ultrasound Inadequate Benign  
       
Growth or 
Clinical change 
Surgery Follow-up  
     
T4 Suppression    
     
Repeat FNA    
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REVIEW OF LITERATURE 
“Diagnosis by Aspiration is as reliable as the combined intelligence 
of the clinician and pathologist makes it”. 
- Fred W. Stewart (1933) 
 There is nothing new under the sun. During medieval times the 
Arabian physician Abul Casim described the needle puncture of the 
thyroid to diagnose different types of Goitre (Anderson). Needle 
aspiration biopsy was recorded by Kun in 1847. There was a brief 
flowering of interest in cytologic techniques in the late 1920s and early 
1930s as reported in the classic papers of Dudgeon and Patrick from 
England who used cytologic scrape preparations of excised tissue. 
In the United States Hayes Martin, a head and neck surgeon, 
Edward Ellis and Fred Stewart reported the use of 18 gauge needles to 
obtain biopsy specimen from patients. In 1923 Papanicolaou presented 
his ‘New Cancer Diagnosis’ later known as ‘Pap Smear’. 
After world war II Scandinavian and North American workers used 
the designation ‘Fine needle aspiration biopsy’ or ‘aspiration biopsy 
cytology’ for both the act as a whole and for the operative procedure38. 
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 Thomson preferred the term ‘Thin needle selective sampling’39. 
Zajdela who introduced non-aspiration technique called it ‘Fine needle 
sampling’43. 
Svante R. Orell, stated that the ‘Fine needle aspiration cytology’ is 
still an acceptable description of the whole of the act inspite of the facts 
that aspiration is not always used. They referred the material expressed 
from the needle as samples, smears or aspirates38. 
Today because of its numerous advantages fine needle aspiration 
biopsy is widely used and has a proven track record as a safe and reliable 
method of making a morphologic diagnosis. 
Fine needle aspiration biopsy is best viewed as a chain of events in 
which the biopsy itself is only one link and not the first on the road to a 
proper diagnosis. The procedure actually begins well before the biopsy is 
performed. Clinical information is crucial in the evaluation of a biopsy 
specimen to arrive at the proper clinico pathologic diagnosis. 
Thyroid nodules are more common in women (4:1), oldage, history 
of radiation exposure and a diet deficient in iodine. The prevalence of 
thyroid nodules steadily increases with age beginning in childhood. New 
nodules become clinically detectable at a rate of about 0.1% per year. 
Since it would be impossible to operate on every patient with a 
goitre to find the few with cancer various clinical parameters are used to 
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define low and high risk groups for cancer (Green span 1974, Thomas 
1976, De Groot 1983). These parameters include history, physical 
examination, diagnostic imaging, laboratory findings particularly ‘fine 
needle aspiration biopsy’9,19. 
Numerous scientific articles and reviews attest to use of fine needle 
aspiration biopsy of the thyroid as  
¾ Simple 
¾ Accurate 
¾ Fast  
¾ Economic 
as well as SAFE method of diagnosis of thyroid disorders1. (Abu Nema 
1987, J. Anderson, Baskin, Bodo). 
 Depending on the patient population, approximately 60-75% of 
fine needle aspiration biopsies are diagnosed as benign, approximately 5-
10% as malignant and the remainder as suspicious. 
 Gharib et al in 1988 studied the diagnostic accuracy can be as high 
as 95% or better for satisfactory specimens. 
 Frable in 1980, 1986, La Rossa 1991 et al studied the positive 
predictive values ranging from 89-98% and negative predictive values 
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94-99%. Its potential to reduce unnecessary operations is significant. The 
greatest risk of false negative diagnosis is in relation to cystic neoplasms 
mainly cystic papillary carcinomas14,26. 
 La Rossa et al found a false negative rate of 6.4% for cystic 
nodules, whereas it was only 1.4% for solid nodules. False negative 
diagnosis also arise from inadequate samples, geographic misses of the 
lesion, dual pathology and errors in interpretation. Clinical and radiologic 
findings must be taken into account. Repeated fine needle aspiration 
biopsy sampling over a period of time to reinforce a benign diagnosis or 
in indeterminate cases particularly if ultra sound guidance is used reduces 
the false negative rate26. 
Cytology of normal thyroid: 
1) Follicular epithelial cells are fragile and bare nuclei are common. 
These are similar in size and shape to normal lymphocytes. The 
nuclei are rounded or slightly oval with a smooth outline. 
2) Colloid stains blue - purple and forms a thin membrane like coat 
often with folds and cracks.  
Hurthle cells: 
 The Hurthle cell is a cell in the thyroid which has been associated 
with debate and confusion. The debate surrounds several aspects of the 
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cell including its origin, its functional state and the clinical implications 
of nodules composed of these cells. 
 Oncocytes from the Greek word ‘swell’ also known as Hurthle 
cells, Oxyphilic cells or Askanazy cells are characterized by abundant 
granular cytoplasm due to abundant accumulation of mitochondria. This 
is a phenomenon of metaplasia and indicates degenerated follicular 
epithelial cells that occurs in inflammatory disorders such as thyroiditis or 
situations that results in stress. ‘Proliferation of oncocytes gives rise to 
hyperplastic and neoplastic nodules’. 
 Oncocytic cells in the thyroid are often called Hurthle cells.  
However this is a misrepresentation. Cells of these features were 
discovered by Askanazy in 1898 in patient with Grave’s disease. In 1936, 
Eisen  studied the characteristic cytoplasmic appearance is due to 
increased number of mitochondria in a patient with Riedel’s thyroiditis.  
 In 1919, James Ewing described two patients with adenocarcinoma 
of the thyroid made of large finely granular eosinophilic cells and 
suggested that they might represent ‘Hypertrophic Hurthle cells of the 
thyroid alveoli’. Since that time the term Hurthle cell is used in the world 
literature to identify the cells that Max Askanazy originally described. 
The cells that Hurthle described were infact ‘C’ cells31.  
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Hurthle cells are found in a wide variety of conditions affecting the 
gland and there fore they cannot be considered specific for any disease 
entity40. 
Occurrence of Hurthle Cells 
Non-Neoplastic 
 
1) Chronic Lymphocytic Thyroiditis  
        and variants. 
2) In nodular goitre  
3) In diffuse toxic goiter 
4) Post irradiation 
5) Post chemotherapy 
6)  As aging process 
                  Neoplastic 
 
Follicular Hurthle cell adenomas 
and Carcinomas. 
Rare variants of papillary and 
medullary Carcinomas. 
  
Kauffmann et al studied the significance of Hurthle cells in thyroid 
nodule fine needle aspiration cytology samples. He concluded that 
density of Hurthle cells in FNAC ranged from 20-100% the presence of 
more than 50% Hurthle cells in FNAC correlated with benign or 
malignant Hurthle cell neoplasm. Hurthle cell carcinomas displayed more 
than 90%. Hurthle cells in FNAC and surgery is indicated for all nodular 
lesions with more than 50% Hurthle cells24. 
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 Kumar et al in their study " Aspiration Cytology of Hashimoto's 
thyroiditis in an endemic area" has pointed out that fine needle aspiration 
plays a significant role in the diagnosis of thyroid lesions due to its 
simplicity and low cost. Hashimoto's thyroiditis is the second most 
common thyroid lesion next to endemic goitre diagnosed on fine needle 
aspiration in iodine deficient areas. 
 Presentation as a nodular thyroid is common. Diagnosis of 
Hashimoto's thyroiditis is likely to be missed in smears showing 
cytological evidence of hyperplasia  or abundant  colloid. Careful 
screening for Hurthle cell change and lymphocytic infiltration into 
follicular cells should be carried out. In equivocal cases multiple 
punctures and immunological investigations are helpful. In antibody 
negative cases repeat fine needle aspiration at follow-up useful. Marked  
lymphocytic infiltration and Hurthle cell change may indicate a 
hypothyroid state but hormonal levels  are required for management25. 
Hurthle cells with associated lesions. 
Laurie Mac Donald and Hossein M. Yazdi determined the accuracy 
of cytologic interpretation in the diagnosis of Hashimoto’s Thyroiditis. 
The results supported the value of fine needle aspiration biopsy in the 
23 
diagnosis of Hashimoto’s thyroiditis. Two main sources of diagnostic 
error were the presence of hyperplastic follicular cells and sampling error. 
 The presence of hyperplastic follicular cells in fine needle 
aspiration biopsy samples from Hashimoto’s Thyroiditis may mimic 
follicular neoplasm. Adequate sampling is important when there is an 
associated lesion. The diagnosis of lymphocytic thyroiditis should not be 
made when only a few lymphocytes are seen. Pleomorphic Hurthle cells 
may be present in aspirates from Hurthle cell neoplasm27. 
Esther Ravinsky et al refined the cytodiagnostic criteria for 
distinguishing Hashimoto’s thyroiditis from thyroid neoplasms. 
Diagnostic criteria separating Hashimoto’s thyroiditis from thyroid 
neoplasms12. 
 Hashimoto’s thyroiditis Thyroid neoplasms 
Cell 
arrangements 
Flat sheets and clusters with a 
few single cells. Cohesive 
tissue fragments with cells 
well oriented one to the other. 
Syncytial type loosely 
cohesive tissue fragments 
with cells poorly oriented 
one to the other as well as 
isolated single cells. 
Nuclear 
chromatin 
pattern 
Bland and even Finely granular, coarsely 
granular or clumped 
Nucleoli Identifiable Macro nucleoli in Hurthle 
cell neoplasms. 
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Giorgadze T, Rossi Ed et al studied the risk of malignancy in cases 
diagnosed as Hurthle cell neoplasm and identified clinical features that 
may help in predicting malignancy in patients with fine needle aspiration 
diagnosis of Hurthle cell neoplasm. The risk of malignancy was greater in 
nodules measuring more than 2 cm, in patients who were are more than 
40 yrs old and was found greater in male patients, than in female patients. 
However the difference was not statistically significant. The diagnosis 
Hurthle cell neoplasm  / follicular neoplasm with oncocytic features 
carries a higher risk of malignancy as compared with a diagnosis of 
follicular lesion / neoplasm. Clinical features including size of the nodule, 
age and possibly sex of the patient can be a part of the decision analysis 
in selecting a patient for surgery18. 
Thompson et al called attention to large pyknotic nuclei in Hurthle 
cells in non-neoplastic Hurthle cell nodules37. 
Sudha R. Kini studied the difficulties in making the cytologic 
differentiation between surgical and non-surgical Hurthle cell lesions and 
had enlisted the following criteria37. 
25 
Cytomorphology of Hurthle cell Tumours37. 
 
1. 
2. 
 
3. 
 
4. 
5. 
 
6. 
7. 
 
8. 
Monomorphic cell population. 
Cells oval-polygonal with  abundant granular cytoplasm that stains 
eosinophilic, cyanophilic or amphophilic. 
Nucleus slightly eccentric, small round to oval with finely granular 
chromatin. 
Prominent macro nucleolus. 
Cells mostly in isolated or in loose groups, occasionally sheets or 
follicles. 
Scanty colloid. 
Tissue fragments with marked nuclear pleomorphism suggest 
malignancy. Must be differentiated from auto immune thyroiditis. 
No inflammatory cells in the background. 
 
Danielle D, Elliott in their study " Fine needle aspiration Biopsy of 
Hurthle cell lesion of the thyroid gland" concluded, that fourteen 
cytologic features were examined and 6 were found to be statistically 
significant in identifying Hurthle cell neoplasm. The following four 
features when found in  combination were found to be highly predictive 
of Hurthle cell neoplasm8. 
* Non macro follicular architecture 
* Absence of colloid 
* Absence of inflammation 
* Presence of transgressing blood  vessels 
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Jorge L. Gonzalez et al studied many statistically significant 
cytological differences between Hurthle cell Tumour and non-neoplastic 
Hurthle cell lesions, statistically significant features are 
1) A high percentage of >90% Hurthle cells 
2) Single Hurthle cells >10% 
3) Cellular dyshesion 
4) Large nucleoli 
5) Significant nuclear enlargement absence of plasma cells, 
macrophages and few lymphocytes22. 
The majority of fine needle aspirates of the thyroid that 
demonstrate a predomnance of Hurthle cells are diagnosed as suspicious 
for Hurthle cell neoplasm. Only a minority of these patients are found to 
have carcinoma at the time of resection. Renshaw AA attempted to define 
criteria  that were more specific for Huirthle cell carcinoma without a loss 
in sensitivity. 
Hurthle cell carcinomas could be identified using a total of five 
criteria. Predominantly  Hurthle cells and scant colloid and atleast one of 
either small cell dysplasia (cytoplasmic diameter less than twice the 
nuclear diameter with often quite bland cells), large cell dysplasia 
(greater than twice the variation in nuclear diameter) large cells typically 
demonstrate prominent nucleoli and irregular nuclear outline, crowding 
(Nuclei touching) and dyshesion (single cells). 
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He concluded that by focusing on criteria for Hurthle cell 
carcinoma rather than all Hurthle cell neoplasm criteria can be developed 
that improve the specificity without a loss of sensitivity34. 
Dr. Gita Jayaram in ‘Problems in the interpretation of Hurthle cell 
populations in Fine needle aspirates’ had cases with Hurthle cell 
population showing features of pleomorphism in the presence of a scant 
number of lymphocytes. Such cases needed to be evaluated very carefully 
with the help of antibody tests in order to distinguish Hurthle cell lesions 
requiring surgical intervention from those that do not21. 
Diya I. Aladeen et al studied the predominance of Hurthle cells in 
Fine needle aspiration  biopsy ‘A predominance of Hurthle cells was 
defined by a smear in which Hurthle cells comprised greater than 50% of 
the cellular content’. As a result thyroidectomy is recommended for all 
patients with a thyroid nodule and a predominance of Hurthle cells on 
Fine needle aspiration biopsy specimen10. 
Gia Khanh Nguyen et al concluded that Tumour cells with ill 
defined cytoplasm and prominent nucleoli in syncytial clusters and 
abundant naked tumour cell nuclei in the Fine needle aspirate of a thyroid 
nodule should alert the observer about the strong possibility of an Hurthle 
cell carcinoma17.  
Sudha R. Kini et al has pointed out that ‘Horn in 1951 stated that 
the papillary or follicular cancers composed of Hurthle cells do not 
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behave differently from the usual follicular or papillary carcinomas. He 
felt that the architectural pattern rather than the cell type predicted the 
behaviour of the tumour37. 
Role of Morphometry in the diagnosis of Hurthle cell Neoplasm. 
 Stefan E. Pambucian et al studied that nucleolar features such as 
size, variation in size and roundness may be more effective than cellular 
or nuclear features in differentiating Hurthle cell Adenomas and Hurthle 
cell carcinomas in Fine needle aspiration cytology smears36. 
“Morphometric studies on Nuclei in smears of Fine needle 
aspiration from oxyphilic tumours of the thyroid gland” by Lennart 
Bondeson et al also concluded that mean nuclear size and or degree of 
anisokaryosis is of no practical value in distinguishing between benign 
and malignant thyroid neoplasms of the oxyphilic type5. 
Andrew flint in “Cytophotometric measurements of Hurthle cell 
Tumours of the thyroid gland stated that statistically significant 
association was found between aneuploidy and tumour invasion. 
However measurement of the percentage of cycling tumour cells as well 
as nuclear size and shape were not useful in separating benign from 
malignant neoplasms2. 
Heppe H, Armin et al reviewed 34 patients treated between 1972 
and 1984. On the basis of strict histopathologic criteria 14 patients with 
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Hurthle cell hyperplasia, 10 with Hurthle cell Adenoma and 10 with 
Hurthle cell carcinoma were identified. Lobectomies were performed in 
patients with tumours considered histopathologically benign and total 
thyroidectomy in patients with histologically malignant lesions. 
Therefore appropriate treatment for Hurthle cell Adenoma and 
nodular hyperplasic is a lobectomy. Total thyroidectomy is reserved for 
Hurthle cell carcinoma primarily because of the high incidence of 
bilateralism20. 
 Wasvary H, Ezako. P also concluded unilateral thyroid lobectomy 
is adequate therapy for the treatment of Hurthle cell Adenoma with total 
thyroidectomy reserved for patients with histologically proven 
carcinoma42. 
 Caplan RH, Abellera RM et al reviewed the pathology and clinical 
follow-up of 26 patients with Hurthle cell adenomas and three patients 
harboring Hurthle cell carcinomas. Although benign lesion could not be 
distinguished from malignant tumours by cytologic features alone, other 
pathologic features allowed differentiation. A total thyroidectomy was 
performed in only one patient the remaining patients were treated by less 
extensive operations. None of the patients with benign adenomas 
including those tumours greater than 2cm in diameter experienced 
recurrent or metastatic disease. The period of observation varied from 2 - 
22 yrs. They concluded that lobectomy is a satisfactory operation for 
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removal of Hurthle cell adenoma and reserve total or  near- total 
thyroidectomy for cases displaying pathologic evidence of malignancy6. 
 Nesland  JM et al Studied `Ultra Structural features of Hurthle cells 
in neoplastic and non - neoplastic lesions'. The presence of distinct 
smooth surface cells interspersed with cells with many microvilli is 
almost a pathgnomonic scanning electron microscopic feature of benign 
and malignant Hurthle  cell lesions. Most Hurthle cells stained positively 
for thyroglobulin in all cases but no immuno reactivity for CEA  and 
calcitonin was found30. 
 Pisani T, Pantellini F et al studied the immuno cytochemical 
expression of Ki67 and laminin in Hurthle cell adenomas and carcinomas. 
Benign Hurthle cell lesions with a higher cellular proliferation associated 
with an increased laminin expression could define a subset of lesion 
prone to malignant transformation. Conversely all cases with low 
expression of both laminin and Ki 67 always correspond to adenomas. 
The different expression of these two antibodies on FNAC can provide a 
further tool for the pre operative identification of lesions at low risk of 
malignancy thus avoiding unnecessary surgery32. 
 Kanthan R, Radhi JM, et al Studied " The immuno histochemical 
analysis of thyroid adenomas with Hurthle cells" Their aim was to 
elucidate the relation ship between the normal uninvolved thyroid and the 
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adenoma and also to evaluate the role of histo chemical studies in 
adenomas with Hurthle cell changes. 
 A panel of 9 antibodies directed against thyroglobulin, high 
molecular weight keratin, low molecular weight keratin, P - 53, bcl - 2, 
Epithelial  membrane antigen carcino embryonic antigen, S 100 and 
HMB - 45 were used, Majority of Hurthle cells and adenomas with 
predominant  Hurthle cells had an increased percentage of P - 53 
staining23. 
 Zeppa P, Ferrara G, " L - Thyroxine effects on thyreocytes and 
Hurthle cells in nodular hyper plastic goitre on Fine needle aspiration 
samples". 
 A morpho metric study was performed on thyreocytes and Hurthle 
cells. Results suggest that morphometry may be useful in the follow-up of 
nodular hyperplastic goitre to evaluate the effects of  L - Thyroxine and 
that this therapy reduces the size of thyreocytes. However the therapy has 
little value or no effect on Hurthle cells44. 
 "Hurthle cell tumours of the thyroid. A flow cytometric DNA 
analysis" by A.K - el - Naggar J.G. Batsakis has shown that nuclear DNA 
ploidy alone does not distinguish benign from malignant Hurthle cell 
tumour. Diploid DNA Hurthle cell carcinomas behave far less 
aggressively than aneuploid Hurthle cell carcinomas and all patients with 
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aneupolid carcinomas died of their disease or are alive with persistent 
carcinoma29. 
 Wallin G, Backdhal, M, Lundell G, Auer G in their study " Nuclear 
DNA content and prognosis in Hurthle cell tumours of the thyroid gland". 
Concluded that DNA measurement in morphologically identified single 
tumour cells performed either on fine needle aspiration biopsy material or 
on histological sections from the primary tumours identifies those 
patients with a good versus a bad prognosis. These results correlate well 
with the findings in earlier studies about paprillary, follicular and 
medullary thyroid tumours41. 
 Bronner MP, Clevenger CV et al examined paraffin embedded 
surgical biopsy material from 17 Hurthle cell tumours of the thyroid for 
DNA content by flow cytometry to assess the diagnostic and prognostic 
utility of ploidy determinations in these rare tumours. Both adenomas and 
carcinomas were studied. As a control for methods, ten randomly selected 
normal autopsy thyroids were analyzed all of which demonstrated normal 
diploid DNA content. The findings demonstrated the limited value of 
aneuploidy or polyploidy as diagnostic features for maligrancy in Hurthle 
cell tumours of the thyroid. As for prognosis there does not appear to be 
any for unfavourable prognostic significance for abnormal DNA content 
in histologically benign Hurthle cell tumours treated by surgical excision 
because no metastases or recurrences occured in this group. Preliminary 
data suggest that aneuploidy may however have an important prognostic 
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value for histologically defined Hurthle cell carcinomas because the only 
patient to die from the tumour in this series had an aneuploid Hurthle cell 
carcfinomas4. 
 McIvor NP, Freeman JL et al studied the "Value of fine needle 
aspiration in the diagnosis of Hurthle cell neoplasms". They concluded 
that aspiration cytology can differentiate non - neoplastic from neoplastic 
Hurthle cell lesions with high accuracy, but that the differentiation 
between benign and malignant lesions is less reliable28. 
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RESULTS AND OBSERVATION 
Table - 1: Showing age wise distribution of 180 cases 
Age group No. of cases 
10-20 15 
21-30 58 
31-40 58 
41-50 27 
51-60 14 
61-70 6 
Total 178 
 
 For 2 cases Age was not recorded 
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Table - 2: Showing sex incidence 
Sex No. of cases 
Males 7 
Females 173 
Total 180 
 
 
Sex Incidence of the Thyroid Cases
Males
4%
Females
96%
Males
Females
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Table - 3: Showing presentation of cases 
Anatomical diagnosis No. of cases 
Solitary nodule thyroid 54 
Multi nodular goitre 55 
Diffuse goitre 71 
Total 180 
 
 
 
Presentation of Cases
SNT
30%
MNG
30%
Diffuse
40% SNT
MNG
Diffuse
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Table - 4: Showing physiological diagnosis of 180 cases  
Physiological diagnosis No. of cases 
Eu thyroid 165 
Hyper thyroid 8 
Hypo thyroid 7 
Total 180 
 
 
Physiological Diagnosis of 180 Cases
Euthyroid
92%
Hyper thyroid
4%
Hypo thyroid
4%
Euthyroid
Hyper thyroid
Hypo thyroid
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In our study of  180 cases of Fine Needle Aspiration of Thyroid, it 
was found that 73 cases showed a predominance of Hurthle cells. 
 The sex incidence was found to be 2 males and 71 females that is 
in the ratio of 1:35.5.  The age incidence was found to be between 16 
years and 63 years. 
 The clinical presentation was as follows : 
Solitary nodule 12 
Diffuse 37 
Multiple nodules 24 
Total 73 
 
 The conditions which showed a predominance of Hurthle cells 
were classified as :- 
Non - Neoplastic 
Hashimoto's 
Nodular Colloid Goitre 
Toxic Goitre 
59 
10 
1 
Neoplastic 
Follicular Neoplasm 
Papillary Carcinoma 
Hurthle  cell  Neoplasm 
1 
1 
1 
 
The study of the cytological smears was based on the distribution 
of Hurthle cells, their individual cytomorphology, nuclear features, 
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cohesiveness associated cells and the study of background in which the 
cells were distributed. 
Of the 73 cases which showed Hurthle cells, surgery was done only 
for 18 cases. As most of the cases were diagnosed as Hashimoto's 
thyroiditis and colloidgoitre which did not require surgical intervention 
we had histopathological correlation only for 18 cases. The results of 
which were tabulated as follows 
Cytohistologic Results in cases where Hurthle cells are 
prominent 
 
Cytologic Diagnosis Histologic diagnosis No.of Cases 
Hashimoto's thyroiditis Hashimoto's thyroiditis 6 
Hashimoto's thyroiditis Nodular colloid Goitre 2 
Hashimoto's thyroiditis Nodular colloid Goitre with 
thyroiditis 
3 
Toxic Goitre Toxic  Goitre 1 
Nodular colloid Goitre Toxic  Goitre 1 
Nodular colloid Goitre Hashimoto's thyroiditis 2 
Hurthle cell Neoplasm Hurthle cell adenoma 1 
Follicular Neoplasm Follicular Adenoma 1 
Papillary carcinoma Papillary carcinoma 1 
Total 18 
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 For the rest of the cases, a clinical follow-up was done. Cases 
diagnosed as Hashimoto's thyroditis proved to the same by Anti body test 
and cases diagnosed as colloid goitre showed marked improvement with 
drug therapy. 
The cellularity of aspirates from Hashimoto's thyroditis varied 
from mild - moderate with lymphocytic infiltrate being mild - moderate.  
The amount of colloid was scanty in majority of the smears, with 
oceassional smears showing moderate colloid. There was an admixture of 
epithelial cells, lymphocytes and plasma cells. The epthelial cells were 
found to be arranged in monolayered  sheets and in small clusters. 
 In aspirates from Hashimoto's thyroiditis Hurthle cells showed dark 
nucleus with mild - moderate nuclear polymorphism. The nuclear  
chromatin pattern was bland and even. This type of atypia is called 
regressive atypia which is considered to be characteristic of non - 
neoplastic lesion12. Some of the smears stained with Maygrunwald 
Giemsa showed identifiable nucleoli with few binucleated cells. 
 The Hurthle cell morphology in aspirates from nodular colloid 
goitre showed honey comb pattern of arrangement and were interspersed 
by regular follicular epithelial cells. The differentiating feature between 
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the Hurthle cells and regular epithelium was increase in size and the 
presence of  abundant granular eosinophilic cytoplasm. 
 The aspirates of toxic goitre showed features of regular follicular 
epithelial cells arranged in flat monolayered sheets with cytoplasmic 
vacoulation with background showing lymphocytes and Hurthle Cells. 
 In aspirates from thyroid neoplasm the epithelial cellularity was 
found to be greater than that of Hashimoto's thyroiditis. 
 In smears from papillary carcinoma, there was high cellularity with 
flat monolayered sheets of follicular epithelial cells which exhibited 
nuclear grooves  and pseudo nuclear inclusions. Hurthle cells were seen 
in sheets. 
 The aspirates from pure Hurthle cell lesion showed a monomorphic 
population of Hurthle cell arranged both in loose clusters and in singles. 
There was no colloid or lymphoplasma cytic infiltrate in the background. 
Such lesion proved to be well encapsulated Hurthle cell adenoma. 
 Aspirates from follicular neoplasm showed micro follicular 
arrangement of follicular epithelial cells with a drop of colloid, in a 
background of Hurthle cells and lymphocytes Histologically also the case 
was proved to be follicular adenoma with Hurthle cell nodule. 
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 The differentiating features of Hurthle cells in neoplastic and non-
neoplastic lesions of thyroid. 
Neoplastic lesions Non - neoplastic 
A High percentage of Hurthle cells 
mostly isolated or in loose cohesive 
sheets 
Hurthle cells in flat sheets and 
clusters with a few single cells. 
Monomorphic cell population with 
cells oval - polygonal with 
abundant granular eosinophilic 
cytoplasm, eccentric nuclus with 
finely granular or clumped 
chromatic 
Nuclear chromatin pattern is bland 
and even 
Prominent macronucleoli  Identifiable nucleoli 
No inflammatory cells in the 
background 
Inflammatory cells in the 
background 
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DISCUSSION 
 Hurthle cell nodules of the thyroid can result from non - neoplastic 
conditions such as Hashimoto's Thyroiditis, adenomatous Goitre and 
graves disease. Conversely neoplastic nodules may be composed 
predominantly of Hurthle cells. They are referred to as Hurthle cell 
tumours and represent approximately 5% of thyroid neoplasms. 
 Hurthle cell neoplasms in turn can be categorized as adenomas 
which are usually unilateral and carcinomas which have a high incidence 
of bilaterality. 
 Hurthle cell tumours have been a source of controversy for several 
decades. In terms of behaviour  studies support that although Hurthle cell 
adenomas behave in a benign fashion Hurthle cell carcinomas pursue a 
much more aggressive course than do follicular carcinomas. 
 Unequivocal capsular / vascular invasion is the `sine qua non' 
criterion for the diagnosis of Hurthle cell carcinoma. 
 Fine needle aspiration of the thyroid is a reliable relatively non - 
invasive method for identifying Hurthle cell nodules likely to be 
neoplastic and requiring surgical excision for careful histological 
evaluation. 
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 The diagnosis of Hashimoto's thyroiditis on fine needle aspiration 
cytology samples is made when lymphoid and Hurthle cell components 
are present in varying proportions. Problems may arise when the 
proportion of these two cell components are markedly deviated. 
 Fine needle aspiration was successful in detecting Hashimoto's 
thyroiditis in six cases. In three cases Hashimoto's thyroiditis was 
diagnosed but  did not sample the associated lesioon. 
 These three cases presented as multi nodular goitre27. Sampling 
error in these cases stresses the importance of adequate sampling from 
several areas of thyroid lesions especially when there is an associated 
nodule. 
 In the remaining two cases of Hashimoto's thyroiditis, 
histologically nodular colloid goitre was reported. A small population of 
lymphoid cells from peripheral blood was considered as the source of 
these cells causing misinterpretation. According to laurie MacDonald, A 
diagnopsis of lymphocytic thyroiditis should not be made when only a 
few lymphocytes are present27.  
 Dr.Gita Jayaram in "Problems in the interpretation of Hurthle cell 
populations in fine needle aspirates" have encountered these Hurthle cells 
showing features of plcomorphism in the presence of scant number of 
lymphocytes such cases needs to be evaluated very carefully with the 
help of antibody tests21. 
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 The aspirates from non - neoplastic Hurthle cell nodules of Nodular 
goitre tend to exhibit tissue fragments of Hurthle cells that display a 
`Honey comb' pattern. This is incontrast to Hurthle cell neoplasms in 
which a dissociated pattern are seen. Also in non - neoplatic lesions, the 
Hurthle cells less commonly display the characteristic nuclear 
morphology. Macronucleolus is infrequently seen. Other features that 
may help in differentiation are the admixture of regular follicular 
epithelium and the frequent occurence of pyknotic nuclei in Hurthle cells. 
 In two cases of  nodular goitre Hurthle cells are associated with 
ordinary follicular cells arranged in large sheets macrofollicles and 
abundant colloid. The amount of colloid is not a statistically significant 
parameter (Gonzalez et al)22. 
 Hashimoto's thyroiditis typically have a scant colloid. But one case 
which had abundant colloid was histological proved as Hashimoto's 
thyroiditis. Nodular goitre may also have scant colloid with Hurthle cell. 
This explains that colloid is not a significant parameter in differentiating 
Hurthle cell lesion from non - neoplastic Hurthle cell lesion. 
 According to Gita Jayaram in "Problems in the interpretation of 
Hurthle cell populations in fine needle aspirates" have encountered these 
cells in thyrotoxic Goitre, Follicular neoplasms and papillary carcinoma. 
In these conditions the problem is alleviated by the presence of features 
specific to the predominant lesion21. 
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 In the case of follicular neoplasm, the thyroid follicular epithelial 
cells are seen in clusters and in micro acinar groupings with colloid. 
Hurthle cells are seen in small groups and in cohesive sheets. 
Histologically well eneapsulated follicular adenoma with Hurthle cell 
component are seen. 
 The presence of Hurthle cells in papillary carcinoma does not 
change the usual behaviour of  papillary carcinoma. The architectural 
pattern rather the cell type predicted the behaviour of the tumour37 (Sudha 
Kini). 
 The accurate diagnosis of Hurthle cell tumour by fine needle 
aspirate is very important. The aspirates from Hurthle cell lesion show 
monomorphic cells with loosely cohesive tissue fragments as well as in 
singles. The nuclear chromatin is finely granular with prominent nucleoli. 
There were no inflammatory cells in the background. Histological 
sections showed an encapsulated lesion with Hurthle cells in trabecular 
pattern. There was no evidence of invasion. 
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SUMMARY 
 The accurate diagnosis of Hurthle cell neoplasm by needle biopsy 
is very important. Benign hyperplastic nodules of Hurthle cell type were 
commonly seen in Hashimoto's Thyroiditis and nodular goitre. These 
nodules may reach a large size and clinically present as a solitary nodule. 
 From our study a polymorphic cellular pattern containing Hurthle 
cells, normal follicular epithelium and lymphocytes helped in making a 
correct diagnosis of Hashimoto's Thyroiditis.  
 `Regressive atypia' is characteristic of non - neoplastic Hurthle cell 
lesions. 
 Frequent occurrence of pyknotic nuclei in Hurthle cells in non - 
neoplastic conditions is also a helpful differentiating feature. 
 A diagnosis of Hashimoto's Thyroiditis should not be made when 
there is a scant number of lymphocytes. Such cases are needed to be 
evaluated carefully  with the help of antibody test. 
 The following characteristics are helpful in making a diagnosis of 
Hurthle cell neoplasm. 
 A high percentage of dyshesive Hurthle cells with macro nucleoli, 
single Hurthle cells (>10%), absence of inflammatory cells in the 
background. The amount of colloid is not a significant parameter in 
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distinguishing Hurthle cell tumor from non - neoplastic Hurthle cell 
lesion. 
 The presence of Hurthle cells in follicular adenoma and papillary 
carcinoma does not alter the behaviour of the tumour. The architectural 
pattern rather than the cell type predicts the behaviour of the tumour. 
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CONCLUSION 
 From our study it was observed that the cytological features of 
Hurthle cells varied in different lesions of the thyroid, thus enabling us to 
differentiate between non-neoplastic and neoplastic lesions by way of 
which we could guide the clinicians regarding further therapeutic 
management. 
As Hurthle cell Tumours are being a source of controversy for 
several decades, distinction between  benign and malignant Hurthle cell 
tumours is not made out easily by cytology as in the case of Follicular 
neoplasms.  
 Our findings indicate that a high percentage of Hurthle cells 
(>90%) as compared with all follicular cells, with >10% being single 
exhibiting cellular  dyshesion, macronucleoli, nuclear enlargement with 
pleomorphism and few - no lymphocytes is predictive of Hurthle cell 
Tumours. 
 In contrast in non neoplastic lesions Hurthle cells appeared as 
cohesive clusters or sheets without macronucleoli. In Hashimoto's 
Thyroiditis there was often a background of chronic inflammatory cells 
including plasma cells. 
 In Goitre the Hurthle cells were associated with ordinary follicular 
cells arranged in large sheets and macrofollicles with abundant collorid. 
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The amount of colloid in the background is not a significant parameter as 
we have seen in our study that there were cases of Hashimoto's thryoiditis 
which showed abundant colloid which is not a feature of Hashimoto's 
thyroiditis. Likewise there were cases of goitre which showed scant 
colloid with few lymphocytes, thus explaining why lack of colloid is not 
a significant parameter  in differentiating neoplasms of Hurthle cells from 
non neoplastic Hurthle cells. 
 In conclusion, the cytodiagnosis of Hurthle cell lesions of the 
thyroid by fine needle aspiration cytology is challenging since Hurthle 
cell neoplasm and non-neoplastic Hurthle cell nodules have some 
overlapping cytologic features. 
 When Hurthle cell tumour is suspected, surgical excision of the 
lesion should be done for histological evaluation. 
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No Cytology No Age / Sex Anatomical Diagnosis 
Physiological 
Diagnosis 
Cytological Diagnosis Histopathological Diagnosis Biopsy No 
1. 300/05 37/F MNG Euthyroid Toxic Goitre Toxic Goitre 1158/05 
2. 501/105 34/F ® SNT Euthyroid Colloid Goitre Nodular Goitre 531/05 
3. 675/05 55/F SNT Hyper thyroid Colloid Goitre Toxic Goitre 634/05 
4. 889/05 38/F MNG Euthyroid Colloid Goitre Hashimoto’s thyroiditis 1566/05 
5. 981/05 38/F SNT (L) Euthyroid Adenomatous goitre Nodular Goitre 843/05 
6. 1056/05 30/F SNT ® Euthyroid Follicular Neoplasm Nodular Goitre 895/05 
7. 1069/05 32/F Diffuse Euthyroid Colloid Goitre Nodular Goitre 1030/05 
8. 1152/05 48/F MNG Hyper thyroid Toxic Goitre Toxic Goitre 1237/05 
9. 1233/05 45/F MNG Hyper thyroid Adenomatous hyperplasia with toxic Follicular Adenoma 1345/05 
10. 1370/05 19/F SNT ® Euthyroid Nodular Goitre   
11. 1406/05 58/F MNG Euthyroid Nodular Goitre   
12. 1407/05 45/F Diffuse Euthyroid Hashimoto’s thyroiditis   
13. 1423/05 50/F Diffuse Euthyroid Hashimoto’s thyroiditis   
14. 1428/05 32/F Diffuse Euthyroid Hashimoto’s thyroiditis   
15. 1453/05 25/F Diffuse Euthyroid Hashimoto’s thyroiditis   
16. 1467/05 30/F MNG Euthyroid Nodularcolloid goitre Pap.CA 1850/05 
17. 1473/05 37/F Diffuse Euthyroid Nodularcolloid goitre   
18. 1478/05 50/F Diffuse Euthyroid Hashimoto’s thyroiditis   
19. 1480/05 33/F Diffuse Euthyroid Hashimoto’s thyroiditis Adenomatous goitre 1683/05 
20. 1481/05 20/F Diffuse Euthyroid Lymphocytic thyroiditis   
21. 1496/05 42/F Diffuse Euthyroid Colloid goitre   
22. 1501/05 25/F Diffuse Euthyroid Hashimoto’s thyroiditis   
23. 1507/05 65/F Diffuse Euthyroid Colloid goitre   
24. 1509/05 32/F Diffuse Euthyroid Hashimoto’s thyroiditis Hashimoto’s thyroiditis 1735/05 
25. 1527/05 58/M SNT ® Euthyroid Colloid goitre Colloid goitre 1899/05 
26. 1529/05 34/F SNT ® Euthyroid Colloid goitre   
27. 1532/05 37/F MNG Euthyroid Colloid goitre   
28. 1557/05 55/F Diffuse Euthyroid Colloid goitre   
29. 1560/05 45/M MNG Euthyroid Pap.ca thyroid   
30. 1566/05 65/F MNG Hypothyroid Nodular colloid goitre Nodular colloid goitre 2057/05 
31. 1568/05 40/F SNT Euthyroid Hashimoto’s thyroiditis   
32. 1570/05 41/F Diffuse Euthyroid Nodular colloid goitre   
33. 1574/05 23/F Diffuse Euthyroid Adenomatous goitre   
34. 1579/05 22/F Diffuse Euthyroid Hashimoto’s thyroiditis   
35. 1588/05 27/F Diffuse Euthyroid Hashimoto’s thyroiditis Hashimoto’s thyroiditis 1898/05 
36. 1594/05 33/F SNT ® Euthyroid Nodularcolloid goitre Nodular colloid goitre 1402/05 
37. 1596/05 21/F Diffuse Euthyroid Hashimoto’s thyroiditis   
38. 1628/05 63/F SNT Euthyroid Hashimoto’s thyroiditis   
39. 1648/05 30/F Diffuse Euthyroid Nodularcolloid goitre   
40. 1654/05 27/F Diffuse Euthyroid Nodularcolloid goitre   
41. 1655/05 47/F Diffuse Euthyroid Nodularcolloid goitre   
42. 1660/05 65/F SNT Euthyroid Hashimoto’s thyroiditis   
43. 1661/05 40/F MNG Euthyroid Nodularcolloid goitre   
44. 1666/05 28/F Diffuse Euthyroid Nodularcolloid goitre   
45. 1667/05 47/F MNG Euthyroid Nodularcolloid goitre Nodular colloid goitre 2524/05 
46. 1671/05 30/F Diffuse Hyper Nodularcolloid goitre   
47. 1676/05 35/F SNT® Euthyroid Cystic degeneration   
48. 1693/05 32/F Diffuse Euthyroid Hashimoto’s thyroiditis   
49. 1704/05 28/F MNG Euthyroid Hashimoto’s thyroiditis   
50. 1718/05 34/F Diffuse Euthyroid Nodularcolloid goitre   
51. 1719/05 30/F Diffuse Euthyroid Hashimoto’s thyroiditis   
52. 1726/05 50/F ® SNT Euthyroid Nodularcolloid goitre Nodular colloid goitre 1651/05 
53. 1728/05 46/F SNT ® Euthyroid Hashimoto’s thyroiditis   
54. 1732/05 16/F Diffuse Euthyroid Hashimoto’s thyroiditis   
55. 1733/05 32/F Diffuse Euthyroid Hashimoto’s thyroiditis   
56. 1735/05 18/F Diffuse Euthyroid Nodularcolloid goitre   
57. 1736/05 26/F Diffuse Euthyroid Hyperplastic nodule   
58. 1738/05 21/F Diffuse Euthyroid Hashimoto’s thyroiditis   
59. 1740/05 26/F Diffuse Euthyroid Hashimoto’s thyroiditis   
60. 1774/05 52/F SNT ® Euthyroid Nodularcolloid goitre   
61. 1776/05 35/F Diffuse Euthyroid Nodularcolloid goitre   
62. 1778/05 27/F Diffuse Hyperthyroid Toxic goitre   
63. 1789/05 27/F SNT ® Euthyroid Nodularcolloid goitre Nodular colloid goitre 3336/05 
64. 1790/05 27/F ® SNT Euthyroid Adenomatous goitre Pap.CA 1789/05 
65. 1812/05 40/F ® SNT Euthyroid Nodularcolloid goitre   
66. 1826/05 35/F Diffuse Euthyroid Hashimoto’s thyroiditis   
67. 1828/05 M Diffuse Euthyroid Nodularcolloid goitre   
68. 1835/05 30/F Diffuse Euthyroid Nodularcolloid goitre   
69. 1845/05 27/F MNG Euthyroid Nodularcolloid goitre   
70. 1848/05 50/F SNT ® Euthyroid Nodularcolloid goitre   
71. 1849/05 42/F SNT ® Euthyroid Nodularcolloid goitre   
72. 1851/05 35/F Diffuse Euthyroid Nodularcolloid goitre   
73. 1857/05 55/F MNG Euthyroid Papillary Carcinoma  2090/05 
74. 1870/05 35/F Diffuse Euthyroid Nodularcolloid goitre   
75. 1872/05 50/F Diffuse Hyperthyroid Toxic goitre   
76. 1884/05 30/F MNG Euthyroid Nodularcolloid goitre   
77. 1887/05 35/F SNT ® Euthyroid Nodularcolloid goitre   
78. 1894/05 45/F SNT ® Euthyroid Nodularcolloid goitre   
79. 1899/05 25/F MNG Euthyroid Nodularcolloid goitre   
80. 1904/05 24/F SNT ® Euthyroid Nodularcolloid goitre   
81. 1906/05 50/F SNT (L) Euthyroid Nodularcolloid goitre   
82. 1909/05 25/F MNG Euthyroid Nodularcolloid goitre   
83. 1985/05 40/F Diffuse Euthyroid Hashimoto’s thyroiditis   
84. 1986/05 35/F SNT ® Euthyroid Adenomatous goitre   
85. 1987/05 30/F Diffuse Euthyroid Colloid goitre   
86. 1993/05 64/M SNT® Euthyroid Nodularcolloid goitre Nodular colloid goitre 2235/05 
87. 2000/05 50/F Diffuse Euthyroid Hashimoto’s thyroiditis   
88. 2021/05 58/F Diffuse Euthyroid Hashimoto’s thyroiditis   
89. 2042/05 25/F Diffuse Euthyroid Hashimoto’s thyroiditis   
90. 2087/05 25/F MNG Euthyroid Hashimoto’s thyroiditis Hashimoto’s thyroiditis 1981/05 
91. 2121/05 23/F Diffuse Euthyroid Hashimoto’s thyroiditis   
92. 2229/05 40/F Diffuse Euthyroid Hashimoto’s thyroiditis   
93. 2314/05 32/F Diffuse Euthyroid Hashimoto’s thyroiditis   
94. 2319/05 50/F MNG Euthyroid Nodular colloid goitre   
95. 2322/05 45/F MNG Euthyroid Nodular colloid goitre   
96. 2323/05 18/F MNG Euthyroid Nodular colloid goitre Nodular colloid goitre 2472/05 
97. 2324/05 40/F SNT (L) Euthyroid Nodular colloid goitre Nodular colloid goitre 2202/05 
98. 2329/05 30/F SNT ® Euthyroid Nodular colloid goitre Nodular colloid goitre 2064/05 
99. 2334/05 29/F Diffuse Euthyroid Nodular colloid goitre Nodular colloid goitre 2200/05 
100. 2346/05 F MNG Euthyroid Nodular colloid goitre Nodular colloid goitre 2592/05 
101. 2355/05 25/F Diffuse Euthyroid Nodular colloid goitre   
102. 2482/05 20/F Diffuse Euthyroid Hashimoto’s thyroiditis   
103. 2490/05 51/F SNT ® Euthyroid Nodular colloid goitre Nodular colloid goitre 5619/05 
104. 2562/05 66/F MNG Euthyroid Nodular colloid goitre   
105. 2600/05 35/F SNT ® Euthyroid Nodular colloid goitre   
106. 2621/05 40/F MNG Euthyroid Nodular colloid goitre   
107. 2632/05 50/F MNG Euthyroid Pap.CA   
108. 2798/05 25/F SNT ® Euthyroid Nodular colloid goitre Nodular colloid goitre 4797/05 
109. 2800/05 30/F MNG Euthyroid Nodular colloid goitre Hashimoto’s thyroiditis 3800/05 
110. 3309/05 32/F Diffuse Euthyroid Hashimoto’s thyroiditis Hashimoto’s thyroiditis 6485/05 
111. 3353/05 20/F SNT (L) Euthyroid Nodular colloid goitre Nodular colloid goitre 4104/05 
112. 3390/05 40/F SNT ® Euthyroid Hashimoto’s thyroiditis Hashimoto’s thyroiditis 4197/05 
113. 3438/05 32/F Diffuse Euthyroid Toxic   
114. 3443/05 29/F SNT ® Euthyroid Nodular colloid goitre Nodular colloid goitre 3025/05 
115. 3439/05 37/F MNG Euthyroid Hyperplastic goitre   
116. 3440/05 27/F MNG Euthyroid Adenomatous goitre   
117. 3441/05 60/F SNT (L) Euthyroid Nodular colloid goitre   
118. 3442/05 24/F Diffuse Hyperthyroid Toxic goitre   
119. 3444/05 60/M SNT (L) Euthyroid Follicular neoplasm   
120. 3539/05 19/F SNT Euthyroid Hashimoto’s thyroiditis   
121. 3540/05 40/F MNG Euthyroid Hashimoto’s thyroiditis   
122. 3541/05 28/F MNG Euthyroid Hashimoto’s thyroiditis   
123. 3542/05 40/F MNG Euthyroid Nodular colloid goitre   
124. 3543/05 24/F Diffuse Euthyroid Hashimoto’s thyroiditis   
125. 3544/05 32/F MNG Euthyroid Hashimoto’s thyroiditis   
126. 3612/05 40/F Diffuse Hypothyroid Hashimoto’s thyroiditis   
127. 3613/05 20/F MNG Euthyroid Hashimoto’s thyroiditis MNG 5360/05 
128. 3614/05 14/F Diffuse Euthyroid Nodular colloid goitre   
129. 3615/05 24/F Diffuse Euthyroid Hashimoto’s thyroiditis   
130. 3774/05 20/F SNT Euthyroid Hyperplastic goitre   
131. 3775/05 19/F Diffuse Hypothyroid Hashimoto’s thyroiditis   
132. 3776/05 25/F MNG Hypothyroid Hashimoto’s thyroiditis   
133. 3777/05 42/M MNG Euthyroid Hashimoto’s thyroiditis MNG with Hashimoto’s thyroiditis 4807/05 
134. 3778/05 48/F ® SNT Euthyroid Thyroiditis   
135. 3779/05 26/F SNT Hypothyroid Colloid goitre Pap.CAwith Hashimoto’s thyroiditis 3446/05 
136. 3780/05 26/F Diffuse Euthyroid Nodular colloid goitre   
137. 3781/05 15/F MNG Euthyroid Lymphocytic thyroiditis   
138. 3782/05 26/F Diffuse Euthyroid Colloid goitre   
139. 3783/05 25/F Diffuse Euthyroid Hashimoto’s thyroiditis   
140. 3784/05 22/F MNG Euthyroid Hashimoto’s thyroiditis with toxic   
141. 3785/05 26/F MNG Hypothyroid Hashimoto’s thyroiditis   
142. 3786/05 22/F Diffuse Hypothyroid Hashimoto’s thyroiditis   
143. 3787/05 16/F Diffuse Euthyroid Lymphocytic thyroiditis   
144. 3788/05 16/F Diffuse Euthyroid Lymphocytic thyroiditis   
145. 3868/05 39/F SNT (L) Euthyroid Lymphocytic thyroiditis   
146. 3869/05 21/F SNT ® Euthyroid Nodular colloid goitre   
147. 3870/05 35/F MNG Euthyroid Hashimoto’s thyroiditis   
148. 3871/05 19/F MNG Euthyroid Hashimoto’s thyroiditis   
149. 3872/05 35/F MNG Euthyroid Pap.CA   
150. 3873/05 45/F MNG Euthyroid Hashimoto’s thyroiditis   
151. 3910/05 37/M MNG Euthyroid Hashimoto’s thyroiditis MNG with Hashimoto’s thyroiditis 4255/05 
152. 3927/05 23/F MNG Euthyroid Pap.CA Pap.CA 3499/05 
153. 3937/05 33/F MNG Hyperthroid Hurthle cell tumour   
154. 3938/05 27/F MNG Euthyroid Nodular colloid goitre   
155. 3939/05 55/F SNT ® Euthyroid Nodular colloid goitre   
156. 3940/05 35/F MNG Hypothyroid Hashimoto’s thyroiditis   
157. 3941/05 36/F Diffuse Euthyroid Colloid goitre   
158. 3942/05 26/F MNG Euthyroid Nodular colloid goitre   
159. 3943/05 21/F SNT Euthyroid Hashimoto’s thyroiditis Follicular adenoma 3873/05 
160. 3974/05 60/F SNT ® Euthyroid Nodular colloid goitre Nodular colloid goitre 3326/05 
161. 4026/05 46/F MNG Hypothyroid Hashimoto’s thyroiditis   
162. 4027/05 32/F MNG Euthyroid Hashimoto’s thyroiditis   
163. 4028/05 37/F SNT Euthyroid Nodular colloid goitre   
164. 4029/05 35/F SNT (L) Euthyroid Follicular neoplasm   
165. 4030/05 38/F Diffuse Euthyroid Hashimoto’s thyroiditis   
166. 4135/05 57/F SNT ® Euthyroid Nodular colloid goitre Hashimoto’s thyroiditis 5000/05 
167. 4230/05 35/F Diffuse Euthyroid Colloid goitre   
168. 4231/05 33/F SNT ® Euthyroid Nodular colloid goitre   
169. 4239/05 15/F MNG Euthyroid Nodular colloid goitre Nodular colloid goitre 4032/05 
170. 4232/05 25/F MNG Euthyroid Adenomatous hyperplasia   
171. 4233/05 33/F Diffuse Euthyroid Colloid goitre   
172. 5178/05 50/F SNT (L) Euthyroid Colloidcyst Nodular colloid goitre 4254/05 
173. 5327/05 52/F SNT Euthyroid Pap.CA Pap.CA 4932/05 
174. 5362/05 40/F SNT ® Euthyroid Nodular colloid goitre Nodular colloid goitre 4869/05 
175. 5660/05 30/F MNG Euthyroid Nodular colloid goitre Hashimoto’s thyroiditis with focal toxic 5002/05 
176. 6352/05 32/F MNG Euthyroid Hashimoto’s thyroiditis Nodular colloid goitre with Hashimoto’s thyroiditis 5972/05 
177. 6632/05 35/F Diffuse Euthyroid Nodular colloid goitre Hashimoto’s thyroiditis 5928/05 
178. 6966/05 40/F MNG Euthyroid Hashimoto’s thyroiditis Hashimoto’s thyroiditis 5926/05 
179. 5605/04 45/F SNT Euthyroid Hurthle cell tumour Hurthle cell adenoma 6318/04 
180.  31/F SNT (L) Euthyroid Pap.CA Pap.CA  
 
